Sympathetic mechanisms of hypoglycemic counterregulation

Current Diabetes Reviews

Volumn 3, Issue 3, 2007, Pages 185-193

  Hoffman, Robert P ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

ACTH; Antecedent hypoglycemia; Epinephrine; Muscle sympathetic nerve activity; Type 1 diabetes

Indexed keywords

ADRENALIN; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; NORADRENALIN; PRASTERONE SULFATE;

ADRENALIN BLOOD LEVEL; ADRENERGIC ACTIVITY; ALPHA ADRENERGIC STIMULATION; BETA ADRENERGIC STIMULATION; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE COURSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; EXERCISE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPOLYSIS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPINAL CORD INJURY; SYMPTOM;

ADRENERGIC AGENTS; ANIMALS; DIABETES MELLITUS; EXERCISE; GLUCOSE; HEART RATE; HORMONES; HUMANS; HYPOGLYCEMIA; MODELS, BIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 34547837415     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339907781368995     Document Type: Review

References (137)

1. Heller SR, Cryer PE. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia. in humans. Am J Physiol 1991; 261: E41-8.
2. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 1979; 64: 62-71.
3. Asplin CM, Raghu PK, Koerker DJ, Palmer JP. Glucose counter-regulation during recovery from neuroglucopenia: Which mechanism is important? Metabolism 1985; 34: 15-8.
4. Clarke WL, Santiago JV, Thomas L, Ben-Galim F, Haymond MW, Cryer PE. Adrenergic mechanisms in recovery from hypoglycemia in man: Adrenergic blockade. Am J Physiol 1979; 236: E147-52.
5. Hilsted J, Frandsen H, Holst JJ, Christensen NJ, Nielsen SL. Plasma glucagon and glucose recovery after hypoglycemia: The effect of total autonomic blockade. Acta Endocrinol (Copenh) 1991; 125: 466-9.
6. Boyle PJ, Cryer PE. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia. Am J Physiol 1991; 260: E395-402.
7. Souza HM, Hell NS, Lopes G, Bazotte RB. Effect of combined administration of counterregulatory hormones during insulin-induced hypoglycemia in rats: Lipolysis mediated by a beta-adrenergic mechanism contributes to hyperglycemia. Braz J Med Biol Res 1994; 27: 2883-7.
8. De Feo P, Perriello G, Torlone E, et al. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol 1991; 261: E725-36.
9. De Feo P, Perriello G, Torlone E, et al. Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 1991; 260: E203-12.
10. Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM). J Pediatr Endocrinol Metab 1994; 7: 225-34.
11. Singer-Granick C, Hoffman RP, Kerensky Y, Drash AL, Becker DJ. Glucagon responses to hypoglycemia in children and adolescents with iddm. Diabetes Care 1988; 11: 643-9.
12. Taborsky GJ, Jr., Ahren B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998; 47: 995-1005.
13. Bolli G, de Feo P, Compagnucci P, et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983; 32: 134-41.
14. Kinsley BT, Widom B, Utzschneider Y, Simonson DC. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: Effect of glycemic control. J Clin Endocrinol Metab 1994; 79: 1383-9.
15. Kleinbaum J, Shamoon H. Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus. Diabetes 1983; 32: 493-8.
16. Santiago JV, Clarke WL, Shah SD, Cryer PE. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab 1980; 51: 877-83.
17. Hoffman RP, Arslanian S, Drash AL, Becker DJ. Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset iddm. J Pediatr Endocrinol 1994; 7: 235-44.
18. Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987; 79: 777-81.
19. Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in cns drive and not glycemic thresholds. Am J Physiol 2000; 279: E1054-63.
20. Amiel SA, Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987; 36: 518-22.
21. Mitrakou A, Mokan M, Ryan C, Veneman T, Cryer P, Gerich J. Influence of plasma glucose rate of decrease on hierarchy of responses to hypoglycemia. J Clin Endocrinol Metab 1993; 76: 462-5.
22. DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: Neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol 2004; 287: E32-41.
23. Berne C, Fagius J. Skin nerve sympathetic activity during insulin-induced hypoglycaemia. Diabetologia 1986; 29: 855-60.
24. Fagius J, Niklasson F, Berne C. Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes 1986; 35: 1124-9.
25. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621-7.
26. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246-52.
27. Hoffman RP, Sinkey CA, Anderson EA. Hypoglycemia increases muscle sympathetic nerve activity in iddm and control subjects. Diabetes Care 1994; 17: 673-80.
28. Frandsen H, Berne C, Fagius J, Niklasson F, Christensen NJ, Hilsted J. Plasma volume substitution does not inhibit plasma noradrenaline and muscle nerve sympathetic responses to insulin-induced hypoglycaemia in healthy humans. Scand J Clin Lab Invest 1989; 49: 573-81.
29. Paramore DS, Fanelli CG, Shah SD, Cryer PE. Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia. Am J Physiol 1998; 275: E872-81.
30. Paramore DS, Fanelli CG, Shah SD, Cryer PE. Hypoglycemia perse stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia, Diabetes 1999; 48: 1429-36.
31. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin ii receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol 2006; 290: H1706-12.
32. Schlaich MP, Lambert E, Kaye DK et al. Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43: 169-75.
33. Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA. Gender differences in counterregulation to hypoglycaemia. Diabetologia 1993; 36: 460-4.
34. Claustre J, Peyrin L, Fitoussi R, Mornex R. Sex differences in the adrenergic response to hypoglycemic stress in human. Psychopharmacology (Berl) 1980; 67: 147-53.
35. Davis SN, Shavers C, Costa F. Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans. J Clin Endocrinol Metab 2000; 85: 2148-57.
36. Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN. Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 2003; 52: 1749-55.
37. Corrall RJ, Frier BM. Acute hypoglycemia in man: Neural control of pancreatic islet cell function. Metabolism 1981; 30: 160-4.
38. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci U S A 1994; 91: 2863-7.
39. Hamilton-Wessler M, Bergman RN, Halter JB, Watanabe RM, Donovan CM. The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs. Diabetes 1994; 43: 1052-60.
40. Hevener AL, Bergman RN, Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 2000; 49: 8-12.
41. Madsen BK, Holmer P, Ibsen H, Christensen NJ. The influence of captopril on the epinephrine response to insulin-induced hypoglycemia in humans. The interaction between the renin-angiotensin system and the sympathetic nervous system. Am J Hypertens 1992; 5: 361-5.
42. Muntzel MS, Joseph T, Onwumere O. Captopril does not affect reflex increases in adrenal or lumbar sympathetic nerve activity to hypoglycemia in rats. Metabolism 2005; 54: 1679-86.
43. Frizzell RT, Hendrick GK, Brown LL, et al. Stimulation of glucose production through hormone secretion and other mechanisms during insulin-induced hypoglycemia. Diabetes 1988; 37: 1531-41.
44. Sherwin RS, Shamoon H, Hendler R, Sacca L, Eigler N, Walesky M. Epinephrine and the regulation of glucose metabolism: Effect of diabetes and hormonal interactions. Metabolism 1980; 29: 1146-54.
45. Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 1976; 58: 7-15.
46. Davis SN, Dobbins R, Tarumi C, Jacobs J, Neal D, Cherrington AD. Paradoxical insulin-induced increase in gluconeogenesis in response to prolonged hypoglycemia in conscious dogs. Am J Physiol 1995; 268: E521-30.
47. Fanelli CG, De Feo P, Porcellati F, et al. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 1992; 89: 2005-13.
48. Cersosimo E, Garlick P, Ferretti J. Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes 2000; 49: 1186-93.
49. Waldhausl WK, Gasic S, Bratusch-Marrain P, Komjati M, Korn A. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans. Diabetes 1987; 36: 127-35.
50. Sigal RJ, Fisher S, Halter JB, Vranic M, Marliss EB. The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique. Diabetes 1996; 45: 148-56.
51. Hoelzer DR, Dalsky GP, Schwartz NS, et al. Epinephrine is not critical to prevention of hypoglycemia during exercise in humans. Am J Physiol 1986; 251: E104-10.
52. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 1993; 265: E61-7.
53. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85: 1844-52.
54. Maggs DG, Sherwin RS. Mechanisms of the sympathoadrenal response to hypoglycemia. Adv Pharmacol 1998; 42: 622-6.
55. Bonen A, Megeney LA, McCarthy SC, McDermott JC, Tan MH. Epinephrine administration stimulates glut4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 1992; 187: 685-91.
56. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 1987; 79: 1713-9.
57. Kollind M, Adamson U, Lins PE, Hamberger B. Transient insulin resistance following infusion of adrenaline in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 603-6.
58. Boden G, Chen X, Ruiz J, White N, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438-46.
59. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet 1963; 1: 785-9.
60. Magnan C, Gilbert M, Kahn BB. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle. Lipids 1996; 31: 1141-9.
61. Qvisth V, Hagstrom-Toft E, Enoksson S, Moberg E, Arner P, Bolinder J. Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J Clin Endocrinol Metab 2006; 91: 665-70.
62. Thiebaud D, DeFronzo RA, Jacot E, et al. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 1982; 31: 1128-36.
63. Jensen CB, Storgaard H, Holst JJ, Dela F, Madsbad S, Vaag AA. Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men. J Clin Endocrinol Metab 2003; 88: 2775-83.
64. Hoffman RP, Sinkey CA, Dopp JM, Phillips BG. Systemic and local adrenergic regulation of muscle glucose utilization during hypoglycemia in healthy subjects. Diabetes 2002; 51: 734-42.
65. Hoffman RP. Antecedent hypoglycemia does not alter increased epinephrine-induced lipolysis in type 1 diabetes mellitus. Metabolism 2006; 55: 371-80.
66. Stallknecht B, Lorentsen J, Enevoldsen LH, et al. Role of the sympathoadrenergic system in adipose tissue metabolism during exercise in humans. J Physiol (Lond) 2001; 536: 283-94.
67. Avogaro A, Cryer PE, Bier DM. Epinephrine's ketogenic effect in humans is mediated principally by lipolysis, Am J Physiol 1992; 263: E250-60.
68. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest 1987; 79: 207-13.
69. Capaldo B, Napoli R, Di Marino L, Sacca L. Epinephrine directly antagonizes insulin-mediated activation of glucose uptake and inhibition of free fatty acid release in forearm tissues. Metabolism 1992; 41: 1146-9.
70. Hoffman RP, Sinkey CA, Tsalikian E. Effect of local sympathetic blockade on forearm blood flow and glucose uptake during hypoglycemia. Metabolism 1999; 48: 1575-83.
71. Hourani H, Lacy DB, Nammour TM, Abumrad NN, Morris JA. Differential effects of alpha and beta adrenergic blockade on glucose and lactate metabolism during acute stress. J Trauma 1990; 30: 1116-23; discussion 23-4.
72. Stich V, De Giisezinski I, Crampes F, et al. Activation of alpha(2)- adrenergic receptors impairs exercise-induced lipolysis in scat of obese subjects. Am J Physiol 2000; 279: R499-504.
73. Flechtner-Mors M, Ditschuneit HH, Yip I, Adler G. Sympathetic modulation of lipolysis in subcutaneous adipose tissue: Effects of gender and energy restriction. J Lab Clin Med 1999; 134: 33-41.
74. Chiasson JL, Shikama H, Chu DT, Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 1981; 68: 706-13.
75. Katz A, Broberg S, Sahlin K, Wahren J. Leg glucose uptake during maximal dynamic exercise in humans, Am J Physiol 1986; 251: E65-70.
76. Schuit, FC, Pipeleers DG. Differences in adrenergic recognition by pancreatic a and b cells. Science 1986; 232: 875-7.
77. Palmer JP, Henry DP, Benson JW, Johnson DG, Ensinck JW. Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest 1976; 57: 522-5.
78. Havel PJ, Parry SJ, Stern JS, et al. Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. Metabolism 1994; 43: 860-6.
79. Miller RE, Horton ES. Neural release of glucagon is inhibited by hyperglycemia and enhanced by phentolamine. Diabetes 1979; 28: 762-8.
80. Havel PJ, Mundinger TO, Taborsky GJ, Jr. Pancreatic sympathetic nerves contribute to increased glucagon secretion during severe hypoglycemia in dogs. Am J Physiol 1996; 270: E20-6.
81. Havel PJ, Ahren B. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 1997; 46: 801-7.
82. Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791-8.
83. Duncan PM, Hooker EP. The role of sympathetic arousal in discrimination of insulin-produced hypoglycemia. Behav Pharmacol 1997; 8: 389-95.
84. Hoffman RP, Sinkey CA, Anderson EA. Hypoglycemic symptom variation is related to epinephrine and not peripheral muscle sympathetic nerve response. J Diabetes Complications 1997; 11: 15-20.
85. Bottini P, Boschetti E, Pampanelli S, et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in iddm: Evidence for a nonselective defect Diabetes 1997; 46: 814-23.
86. Davis SN, Fowler S, Costa F. Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 2000; 49: 65-72.
87. Sacca L, Sherwin R, Hendler R, Felig P. Influence of continuous physiologic hyperinsalinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest 1979; 63: 849-57.
88. Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Plasma catecholamine responses to hypoglycemia in children and adolescents with iddm. Diabetes Care 1991; 14: 81-8.
89. Kinsley BT, Simonson DC. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 684-91.
90. Wilke RA, Hillard CJ. Decreased adrenal medullary catecholamine release in spontaneously diabetic bb-wistar rats. Role of hypoglycemia. Diabetes 1994; 43: 724-9.
91. Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 93: 2562-71.
92. Israelian Z, Szoke E, Woerle J, et al. Multiple defects in counter-regulation of hypoglycemia in modestly advanced type 2 diabetes mellitus. Metabolism 2006; 55: 593-8.
93. Hoffman RP, Sinkey CA, Kienzle MG, Anderson.EA. Muscle sympathetic nerve, activity is reducedIn iddm before overt autonomic neuropathy. Diabetes 1993; 42: 375-80.
94. Schneider SH, Vitug A, Ananthakrishnan R, Khachadurian AK. Impaired adrenergic response to prolonged exercise in type 1 diabetes. Metabolism 1991; 40: 1219-25.
95. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991; 40: 223-6.
96. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993; 91: 819-28.
97. Hepburn DA, Patrick AW, Brash HM, Thomson I, Frier BM. Hypoglycaemia unawareness in type 1 diabetes: A lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabet Med 1991; 8: 934-45.
98. George E, Marques JL, Harris ND, Macdonald IA, Hardisty CA, Heller SR. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with iddm. Diabetes Care 1997; 20: 1293-8.
99. Robinson AM, Parkin HM, Macdonald IA, Tattersall RB. Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clin Sci(Lond) 1995; 89: 359-66.
100. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993; 42: 1233-7.
101. Davis, SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 1997; 46: 1328-35.
102. Davis SN, Mann S, Galassetti P, et al. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 2000; 49: 1897-903.
103. Peters A, Rohloff F, Kerner W. Preserved counterregulatory hormone release and symptoms after short term hypoglycemic episodes in normal men. J Clin Endocrinol Metab 1995; 80: 2894-8.
104. Fruehwald-Schultes B, Kern W, Deininger E, et al. Protective effect of insulin against hypoglycemia-associated counterregulatory failure. J Clin Endocrinol Metab 1999; 84: 1551-7.
105. Inouye KE, Yoe JTY, Chan O, et al. Effects of insulin treatment without and with recurrent hypoglycemia on hypoglycemic counterregulation and adrenal catecholamine-synthesizing enzymes in diabetic rats. Endocrinology 2006; 147: 1860-70.
106. Lingenfelser T, Buettner U, Martin J, et al. Improvement of impaired counterregulation hormone response and symptom perception by short-term avoidance of hypoglycemia in iddm. Diabetes Care 1995; 18: 321-5.
107. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in iddm. Diabetes 1994; 43: 1426-34.
108. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54: 3592-601.
109. Davis SN, Shavers C, Davis B, Costa F. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 1997; 100: 429-38.
110. Sandoval DA, Ping L, Neill RA, Morrey S, Davis SN. The effects of dehydroepiandrosterone sulfate on counterregulatory responses during repeated hypoglycemia in conscious normal rats. Diabetes 2004; 53: 679-86.
111. Goldberg PA, Weiss R, McCrimmon RJ, Hintz EV, Dziura JD, Sherwin RS. Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. Diabetes 2006; 55: 1121-6.
112. Raju B, McGregor VP, Cryer PE. Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure. Diabetes 2003; 52: 2083-9.
113. Flanagan DE, Keshavarz T, Evans ML, et al. Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia. Diabetes 2003; 52: 605-13.
114. McCrimmon RJ, Song Z, Cheng H, et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest. 2006; 116: 1723-30.
115. de Vries MG, Lawson MA, Beverly JL. Dissociation of hypothalamic noradrenergic activity sympathoadrenal responses to recurrent hypoglycemia. Am J Physiol 2004; 286: R910-5.
116. Sivitz WI, Herlein JA, Morgan DA, Fink BD, Phillips BG, Haynes WG. Effect of acute and antecedent hypoglycemia on sympathetic neural activity and catecholamine responsiveness in normal rats. Diabetes 2001; 50: 1119-25.
117. Herlein JA, Morgan DA, Phillips BG, Haynes WG, Sivitz WI. Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responsea. Endocrinology 2006; 147: 2781-8.
118. Inouye KE, Chan O, Yue JTY, Matthews SG, Vranic M. Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis. Am J Physiol 2005; 288: E422-9.
119. Galassetti P, Mann S, Tate D, et al. Effects of antecedent prolonged exerdise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol. Endocrinol Metab 2001; 280: E908-17.
120. Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, Cryer PE. Hypoglycemia-induced autonomic failure in iddm is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 1994; 43: 809-18.
121. McGregor VP, Greiwe JS, Banarer S. Cryer PE. Limited impact of vigorous exercise on defenses against hypoglycemia: Relevance to hypoglycemia-associated autonomic failure. Diabetes 2002; 51: 1485-92.
122. Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes 2003; 52: 1761-9.
123. Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes. Am J Physiol 2004; 287: E16-24.
124. Galassetti P, Tate D, Neill RA, Richardson A, Leu S-Y, Davis SN. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol 2006; 290: E1109-17.
125. Berlin I, Grimaldi A, Landault C, et al. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab 1988; 66: 273-8.
126. Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE. Reduced beta-adrenergic sensitivity in patients with type, 1 diabetes and hypoglycemia unawareness. Diabetes Care 1998; 21: 1939-43.
127. Trovik TS, Jaeger R, Jorde R, Sager G. Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness. Br J Clin Pharmacol 1994; 38: 427-32.
128. Fritsche A, Stumvoll M, Grub M, et al. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 1998; 21: 1505-10.
129. Fritsche A, Stumvoll M, Haring HU, Gerich JE. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 2000; 85: 523-5.
130. Vea H, Trovik TS, Sager G, et al. Return of beta-adrenergic sensitivity in a patient with insulinoma after removal of the tumour. Diabet Med 1997; 14: 979-84.
131. Divertie GD, Jensen MD, Cryer PE, Miles JM. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans. Am J Physiol 1997; 272: E1130-5.
132. Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. J Clin Endocrinol Metab 2003; 88: 1503-11.
133. Cohen N, Halberstam M, Rossetti L, Shamoon H. Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with iddm. Am J Physiol 1996; 271: E284-93.
134. Avogaro A, Valerio A, Gnudi L, et al. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans. Diabetologia 1992; 35: 129-38.
135. Bolinder J, Sjoberg S, Amer P. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: Evidence of increased beta-adrenoceptor-mediated lipolytic response in iddm. Diabetologia 1996; 39: 845-53.
136. Qvisth V, Hagstrom-Toft E, Enoksson S, Sherwin RS, Sjoberg S, Bolinder J. Combined hyperinsulinemia and hyperglycemia, but not hyperinsulinemia alone, suppress human skeletal muscle lipolytic activity in vivo. J Clin Endocrinol Metab 2004; 89: 4693-700.
137. Wahrenberg H, Lonnqvist F, Engfeldt P, Amer P. Abnormal action of catecholamines on lipolysis in adipocytes of type i diabetic patients treated with insulin. Diabetes 1989; 38: 524-33.